Role of plasma adenosine in the antiplatelet action of hl 725, a potent inhibitor of camp phosphodiesterase: Species differences.
- 1 July 1987
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 47 (2) , 191-200
- https://doi.org/10.1016/0049-3848(87)90376-8
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodPublished by Elsevier ,2002
- Nitrobenzylthioinosine-sensitive and -resistant nucleoside transport in normal and transformed rat cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- In vivo interaction of prostacyclin with an inhibitor of cyclic nucleotide phosphodiesterase, HL 725British Journal of Pharmacology, 1985
- HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitroLife Sciences, 1982
- Species differences in nucleoside transport. A study of uridine transport and nitrobenzylthioinosine binding by mammalian erythrocytesBiochemical Journal, 1982
- Prostacyclin is a circulating hormoneNature, 1978
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- Comparative Effectiveness of Adenosine Analogues as Inhibitors of Blood-Platelet Aggregation and as Vasodilators in ManNature, 1965
- The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart1The Journal of Physiology, 1929